eflornithine has been researched along with Cardiovascular Diseases in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, H | 1 |
| Colao, A | 1 |
| Blume-Peytavi, U | 1 |
| Rice, S | 1 |
| Qureshi, A | 1 |
| Pellatt, L | 1 |
| Orio, F | 1 |
| Atkin, SL | 1 |
1 review available for eflornithine and Cardiovascular Diseases
| Article | Year |
|---|---|
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.
Topics: Acne Vulgaris; Alopecia; Anovulation; Cardiovascular Diseases; Eflornithine; Female; Hirsutism; Huma | 2008 |